J. Safra Sarasin Group has acquired 100% of the shares of MIV Asset Management AG, a Zurich-based medical technology specialist.
Bank J. Safra Sarasin, which currently offers thematic equity strategies to private and institutional investors, said the purchase of the firm – including its flagship MIV Global Medtech fund – highlights its “commitment to growth in asset management with its thematic equity investing capabilities”.
MIV’s investment strategy and organisational structure will remain unchanged. Financial terms of the transaction are not disclosed.
Oliver Cartade, head of asset management and institutional clients division at Bank J. Safra Sarasin, said: “We are thrilled to welcome MIV Asset Management into the J. Safra Sarasin Group. This acquisition aligns perfectly with our strategic vision to strengthen our thematic equity offerings and underscores our commitment to providing clients with unparalleled investment opportunities.
“MIV’s exceptional team and proven track record will be instrumental in driving our growth and innovation in the thematic investing space.”
Christoph Gubler, senior portfolio manager and CEO of MIV Asset Management, added that the firm is “excited to become part of the J. Safra Sarasin Group to ensure the long-term success of our investment strategy in the best interest of investors”.
“We look forward to continuing our success story as part of the J. Safra Sarasin Group,” he said.
